New developments in the treatment of ovarian cancer--future perspectives. - Wikidata - wikimedia - TriplyDB

New developments in the treatment of ovarian cancer--future perspectives.

New developments in the treatment of ovarian cancer--future perspectives.

http://www.wikidata.org/entity/Q37332487

about

Management of relapsed ovarian cancer: a review Bevacizumab in ovarian cancer: A critical review of phase III studies Precision targeted therapy of ovarian cancer MDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circumvent paclitaxel resistance in ovarian cancer.The prognostic significance of anti-angiogenesis therapy in ovarian cancer: a meta-analysis Inhibition of paclitaxel resistance and apoptosis induction by cucurbitacin B in ovarian carcinoma cells.Epac1 knockdown inhibits the proliferation of ovarian cancer cells by inactivating AKT/Cyclin D1/CDK4 pathway in vitro and in vivo.Ovarian cancer targeted hyaluronic acid-based nanoparticle system for paclitaxel delivery to overcome drug resistance.Incidence and mortality of gynaecological cancers: Secular trends in urban Shanghai, China over 40 years.Silencing dishevelled-1 sensitizes paclitaxel-resistant human ovarian cancer cells via AKT/GSK-3β/β-catenin signalling.Specific immunotherapy in ovarian cancer: a systematic review.Potential microRNA-related Targets for Therapeutic Intervention with Ovarian Cancer Metastasis.An antibody to amphiregulin, an abundant growth factor in patients' fluids, inhibits ovarian tumors.

P2860

Q26741755-63501C98-8ACE-4964-B43B-071F6FD463CA Q28076188-6B4932F6-F9E9-4E38-8820-620F29B24AC0 Q28078658-3E3FDF35-9D03-4688-A83A-D2BF915EDEF2 Q35089472-91DDA404-C892-4969-AD15-4ED35F3FEAA7 Q35920527-7B89BA4B-9261-4E3D-B0CF-90C0B717C942 Q38697712-897906DF-6358-45D9-8E9E-8D75FC62378A Q38765821-E983465E-5047-435D-8111-8661A373E5CF Q38822371-56476A9F-2328-4884-ADF5-EE4A6DBE1BCD Q38859106-4EDF6C73-2609-4CB3-B31C-0AEB09C17499 Q38913984-F1603F41-4E98-4912-B68F-C07F9F62988C Q38948893-14F3EACD-BE3F-4800-A605-91B00825CA1D Q49593669-52C823A6-895C-473C-9F10-0E90722D69F6 Q53251841-33FCBF2E-A024-4507-A15F-7C5A7CB80DB0

P2860

New developments in the treatment of ovarian cancer--future perspectives.

http://www.wikidata.org/entity/Q37332487

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

New developments in the treatment of ovarian cancer--future perspectives.

@en

New developments in the treatment of ovarian cancer--future perspectives.

@nl

type

label

New developments in the treatment of ovarian cancer--future perspectives.

@en

New developments in the treatment of ovarian cancer--future perspectives.

@nl

prefLabel

New developments in the treatment of ovarian cancer--future perspectives.

@en

New developments in the treatment of ovarian cancer--future perspectives.

@nl

P1433

Q37332487-03E921F6-4C67-4F98-867A-F11BEEA64020

P1476

Q37332487-B56492A1-007A-45C8-8415-521DCFEA9FF6

P2093

Q37332487-0DC06319-75D9-4167-9770-8C84F8F9B17C

Q37332487-395C15DD-E6EA-46A9-BE44-CCDCD1AD55C1

Q37332487-45724558-DF03-42D8-B142-41936C65D761

P2860

Q37332487-0167D469-8124-4244-BEDB-574E8B923D11

Q37332487-069F3E03-D045-41DE-B79D-76142164EF22

Q37332487-096B9F92-5BA8-41F8-AECF-B75A1DFE37C5

Q37332487-097E583E-E223-4032-83DD-89493B011DD4

Q37332487-0D13EEB0-693E-4B69-8D60-8CD5DFBB5B6C

Q37332487-0E50D2C4-98DA-4384-9F90-3B0E2ACD6B49

Q37332487-0FA0516D-3FB2-4DEF-AB54-61590A744529

Q37332487-17BD3D58-1C15-4D87-ACE3-00B6F9DA0A91

Q37332487-1BA4C972-27FA-4AEE-9BA2-F97570C495D7

Q37332487-1BF68855-3E15-4090-A1D4-A8AF1F5BAA5B

P304

Q37332487-9F208D50-7FD7-4230-A8A0-9736BE9C17BA

P31

Q37332487-A5C8E1CD-AEF3-44C7-A53D-52ABC567DE38

P356

Q37332487-8377358D-AF2E-4AA1-9958-B39721A639CA

P478

Q37332487-686C4B15-0D26-4540-9AD3-A5819489BA59

P577

Q37332487-28BF0C90-E66D-4C15-9151-93C6274C1C73

P5875

Q37332487-F770DF54-3604-4695-89E4-87656FA4F6A5

P698

Q37332487-52F31526-3CF2-4444-AE6B-72BCC0504E77

P921

Q37332487-B4AE6650-A928-49FB-8905-CD6F3699754E

P932

Q37332487-72BE3CAC-8E77-4463-B3EA-60ECB8AEFA7A

P356

P1433

Annals of Oncology

P1476

New developments in the treatment of ovarian cancer--future perspectives.

@en

P2093

J Lopez

http://www.w3.org/2001/XMLSchema#string

S B Kaye

http://www.w3.org/2001/XMLSchema#string

S Banerjee

http://www.w3.org/2001/XMLSchema#string

P2860

The Hallmarks of Cancer

An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor

An activated ErbB3/NRG1 autocrine loop supports in vivo proliferation in ovarian cancer cells

Modes of resistance to anti-angiogenic therapy

The PI3K pathway as drug target in human cancer

High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs

The role of PARP in DNA repair and its therapeutic exploitation

Combining antiangiogenics to overcome resistance: rationale and clinical experience

Resistance and escape from antiangiogenesis therapy: clinical implications and future strategies

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.

P304

x69-x76

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/ANNONC/MDT475

http://www.w3.org/2001/XMLSchema#string

P478

24 Suppl 10

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

274179321

http://www.w3.org/2001/XMLSchema#string

P698

24265409

http://www.w3.org/2001/XMLSchema#string

P921

P932

3836570

http://www.w3.org/2001/XMLSchema#string